Funds holding SILENCE THERAPEUTICS PLC
ISIN US82686Q1013 · United Kingdom · LEI 213800SSURRJBX85SQ91
- Fund holders
- 13
- Of which ETFs
- 4 9 other funds
- Value held
- ≈ 9.3M $ 9.1M $ · 155.2K €
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 482,088 | 5.1M $ | 0.23 % | as of Jul 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 185,777 | 2M $ | 0.02 % | as of Jun 30, 2026 ↗ |
| ALGER SMALL CAP GROWTH FUND ALGER FUNDS | 105,679 | 1.1M $ | 0.54 % | as of Jul 31, 2026 ↗ |
| ALGER SMALL CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 41,292 | 433.2K $ | 0.54 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 29,538 | 203.8K $ | 0.00 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 9,532 | 104.7K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 8,695 | 60K $ | 0.01 % | as of May 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 5,800 | 60.8K $ | 0.02 % | as of Jul 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 2,476 | 17.1K $ | 0.03 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 1,736 | 12K $ | 0.02 % | as of May 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,000 | 11K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 24 | 263.5 $ | as of Jun 30, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 155.2K € | 0.19 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALGER SMALL CAP GROWTH FUND ALGER FUNDS | 0.54 % | as of Jul 31, 2026 ↗ |
| ALGER SMALL CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS | 0.54 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.23 % | as of Jul 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.19 % | as of Dec 31, 2025 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.03 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 0.02 % | as of Jul 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.02 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 0.01 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 12 | +4 | 873,637 | +290.2 % |
| 2026Q2 | 8 | 0 | 223,899 | -1.3 % |
| 2026Q1 | 8 | -1 | 226,939 | +119.2 % |
| 2025Q4 | 9 | 0 | 103,527 | -52.4 % |
| 2025Q3 | 9 | 0 | 217,295 | -12.9 % |
| 2025Q2 | 9 | 0 | 249,607 | -74.0 % |
| 2025Q1 | 9 | -3 | 960,969 | +27.5 % |
| 2024Q4 | 12 | +4 | 753,872 | +571.8 % |
| 2024Q3 | 8 | +4 | 112,221 | +314.1 % |
| 2024Q2 | 4 | +2 | 27,098 | +15.2 % |
| 2024Q1 | 2 | 0 | 23,532 | +29.4 % |
| 2023Q4 | 2 | 18,192 |
Institutional managers
55 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| TCG Crossover Management, LLC | 3,033,560 | 16M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 2,911,438 | 15.3M $ | as of Mar 31, 2026 |
| Redmile Group, LLC | 2,164,777 | 11.4M $ | as of Mar 31, 2026 |
| Nantahala Capital Management, LLC | 2,146,731 | 11.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,234,807 | 6.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,074,191 | 5.7M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 1,020,489 | 5.4M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 952,400 | 5M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 865,784 | 1.7M $ | as of Mar 31, 2026 |
| Tetragon Partners GP Ltd | 630,161 | 3.3M $ | as of Mar 31, 2026 |
| 5AM Venture Management, LLC | 476,200 | 2.5M $ | as of Mar 31, 2026 |
| Jones Hill Capital LP | 301,604 | 1.6M $ | as of Mar 31, 2026 |
| SG Americas Securities, LLC | 286,698 | 1.5K $ | as of Mar 31, 2026 |
| UBS Group AG | 246,937 | 1.3M $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 209,088 | 1.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 204,777 | 1.1M $ | as of Mar 31, 2026 |
| BANK OF MONTREAL /CAN/ | 202,901 | 1.1M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 172,157 | 907.3K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 169,616 | 893.9K $ | as of Mar 31, 2026 |
| Seven Fleet Capital Management LP | 156,759 | 826.1K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 147,668 | 778.2K $ | as of Mar 31, 2026 |
| Ishara Investments LP | 140,500 | 740.4K $ | as of Mar 31, 2026 |
| HSBC HOLDINGS PLC | 122,834 | 640K $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 119,711 | 630.9K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 115,281 | 607.5K $ | as of Mar 31, 2026 |
Declared shareholders of SILENCE THERAPEUTICS PLC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Invus Public Equities, L.P. and 7 others | 7.00 % | 9,934,314 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding SILENCE THERAPEUTICS PLC". https://titelia.com/en/stocks/silence-therapeutics-plc-US82686Q1013